Related Experiment Video
Updated: Jun 22, 2026
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Retinoic acid inhibits dendritic cell differentiation driven by interleukin-4
Juliana Moreira de Sousa-Canavez1, Cristina de Oliveira Massoco, Dewton de Moraes-Vasconcelos
1Genoa Biotechnology SA, Desembargador Eliseu de Almeida, 9th floor, São Paulo, SP, Brazil. jmscanavez@genoabiotec.com.br
Abstract:
All-trans-retinoic acid (atRA) appears to affect Th1-Th2 differentiation and its effects on immune responses might also be mediated by dendritic cell (DC). Nonetheless, studies have been showing contradictory results since was observed either induction or inhibition of DC differentiation. Our aim was to investigate atRA action on human monocyte derived DC differentiation. For this purpose we tested pharmacological and physiological doses of atRA with or without cytokines. Cell phenotypes were analyzed by flow cytometry and function was investigated by phagocytosis and respiratory burst. DC, positive control group, was differentiated with GM-CSF and IL-4 and maturated with TNF-alpha. We demonstrated that atRA effects depend on the dose used as pharmacological doses inhibited expression of all phenotypic markers tested while a physiological dose caused cell differentiation. However, atRA combined or not with cytokines did not promote DC differentiation. In fact, atRA was detrimental on IL-4 property as a DC inductor.
Insights
All-trans-retinoic acid (atRA) has dual effects on dendritic cell (DC) differentiation, with high doses inhibiting markers and physiological doses promoting differentiation. However, atRA ultimately hinders IL-4
Area of Science:
- Immunology
- Cell Biology
- Dendritic Cell Research
Background:
- All-trans-retinoic acid (atRA) is implicated in immune regulation, potentially influencing T-helper cell differentiation and dendritic cell (DC) function.
- Previous research on atRA's effect on DC differentiation has yielded conflicting results, necessitating further investigation.
Purpose of the Study:
- To elucidate the specific effects of all-trans-retinoic acid (atRA) on the differentiation of human monocyte-derived dendritic cells (DCs).
- To determine if atRA influences DC differentiation in a dose-dependent manner and in combination with cytokines.
Main Methods:
- Human monocytes were differentiated into DCs using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4).
- Cells were treated with pharmacological or physiological doses of atRA, with or without cytokines, and maturated with tumor necrosis factor-alpha (TNF-alpha).
- Phenotypic analysis was performed using flow cytometry; functional assays included phagocytosis and respiratory burst assessments.
Main Results:
- Pharmacological doses of atRA inhibited the expression of key DC phenotypic markers.
- A physiological dose of atRA promoted DC differentiation.
- atRA, alone or with cytokines, did not enhance DC differentiation and impaired the inductive capacity of IL-4.
Conclusions:
- The impact of atRA on human monocyte-derived DC differentiation is dose-dependent.
- While physiological atRA levels can support differentiation, it generally antagonizes IL-4's role in DC induction and can be detrimental at higher concentrations.
